Description du projet DEENESFRITPL Un nouveau détecteur à comptage de photons développe les capacités cliniques de la tomodensitométrie La tomodensitométrie est couramment utilisée pour l’imagerie d’une pléthore de maladies, des pathologies cardiovasculaires aux traumatismes. La capacité des détecteurs actuels à obtenir suffisamment d’informations spectrales est toutefois limitée, au même titre que leur résolution spatiale. Le projet PCSCT, financé par l’UE, accompagne la société suédoise Prismatic Sensors AB dans le développement d’une technologie de détecteur au silicium destinée à la tomodensitométrie à comptage de photons qui affiche une résolution spatiale deux fois plus précise, élimine les artefacts et améliore l’efficacité de la dose. Cette technologie sera validée et comparée à des systèmes les plus à la pointe dans le cadre d’un essai clinique à l’hôpital universitaire Karolinska de Stockholm. Afficher les objectifs du projet Masquer les objectifs du projet Objectif Due to its speed, accuracy and availability Computed Tomography (CT) is a routine tool for imaging of cardiovascular disease, stroke, cancer and trauma injuries; every year over 100 million patients are examined using CT, making it one of the most common medical imaging procedures. Despite a significant development, current CT detectors are unable to obtain sufficient spectral information and have a limited spatial resolution. This leads to image artefacts and limited visualization of important details. Healthcare providers are thus forced to use more expensive and slower modalities like MRI and PET, translating in increased healthcare costs and risk since time to treatment is prolonged. Our solution is a novel photon counting spectrally resolved detector, developed and fully owned by the SME Prismatic Sensors. The technology offers a factor two higher spatial resolution, elimination of artefacts and increased dose-efficiency compared to state-of-the-art clinical CT scanners. Millions of people around the world would benefit from our technology through improved diagnostics and speed of care. In addition, radiation dose and the associated risk is dramatically reduced. The project will result in a fully tested and validated photon counting spectral CT detector ready for commercialization. The technology and the added clinical value will be validated and compared with state-of-the art in a clinical trial by radiologists at the Karolinska University Hospital. As an outcome, Prismatic Sensors expects the new patented detector technology to be the future choice for some or all the major global vendors. This will support Europe's position as a world-leader in medical innovation and healthcare technology, as well as improve hospital efficiency and save healthcare costs. Most importantly, it will have a positive impact for the survival odds for a large number of patients worldwide. Champ scientifique engineering and technologymedical engineeringdiagnostic imagingcomputed tomographymedical and health sciencesclinical medicinecardiologycardiovascular diseasesengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsmedical and health sciencesbasic medicineneurologystrokenatural sciencesphysical sciencestheoretical physicsparticle physicsphotons Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Thème(s) EIC-SMEInst-2018-2020 - SME instrument Appel à propositions H2020-EIC-SMEInst-2018-2020 Voir d’autres projets de cet appel Sous appel H2020-SMEInst-2018-2020-2 Régime de financement SME-2 - SME instrument phase 2 Coordinateur PRISMATIC SENSORS AB Contribution nette de l'UE € 2 409 225,00 Adresse ROSLAGSTULLSBACKEN 21 106 91 STOCKHOLM Suède Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Östra Sverige Stockholm Stockholms län Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 3 441 750,00